secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0000950170-25-102419
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma acquires ~$110M in Litecoin, becomes first US-listed company to adopt LTC as primary reserve
--------------------------------------------------------------------------------

- Acquired 929,548 LTC tokens at avg price $107.58; LTC treasury valued at ~$110.4M as of Aug 4, 2025.
- Deployed all net proceeds from July 17, 2025 PIPE Offering with Titan Partners as placement agent.
- Strategy developed with GSR; Litecoin creator Charlie Lee (MEI board member) providing guidance.
- Company plans to update corporate identity and may start Litecoin mining; continues pre-clinical drug pipeline voruciclib.
- First US-listed public company to adopt Litecoin as primary reserve asset for treasury strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000095017025102419/0000950170-25-102419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000095017025102419/meip-20250805.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-102419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer